MedPath
FDA Approval

Colesevelam hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
October 18, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Colesevelam(3.75 g in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Amneal Pharmaceuticals Private Limited

Amneal Pharmaceuticals of New York LLC

915076126

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Colesevelam hydrochloride

Product Details

NDC Product Code
0115-1864
Application Number
ANDA212886
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 18, 2022
Code: P4SG24WI5QClass: ACTIBQuantity: 3.75 g in 1 1
LEMONInactive
Code: 24RS0A988OClass: IACT
MALTODEXTRINInactive
Code: 7CVR7L4A2DClass: IACT
SUCRALOSEInactive
Code: 96K6UQ3ZD4Class: IACT
MAGNESIUM ALUMINUM SILICATEInactive
Code: 6M3P64V0NCClass: IACT
MEDIUM-CHAIN TRIGLYCERIDESInactive
Code: C9H2L21V7UClass: IACT
PROPYLENE GLYCOL ALGINATEInactive
Code: 26CD3J2R0CClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
© Copyright 2025. All Rights Reserved by MedPath